← Evidence map

ArticlePharmacoEconomics - open2025

Cost-Effectiveness of Fruquintinib for Refractory Metastatic Colorectal Cancer in the USA.

Dong-Won Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39377863